Bin Yuan

534 total citations
19 papers, 410 citations indexed

About

Bin Yuan is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Bin Yuan has authored 19 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Bin Yuan's work include Genetic Associations and Epidemiology (3 papers), Cancer Cells and Metastasis (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Bin Yuan is often cited by papers focused on Genetic Associations and Epidemiology (3 papers), Cancer Cells and Metastasis (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Bin Yuan collaborates with scholars based in China, United States and Czechia. Bin Yuan's co-authors include Yanfen Hu, Bogang Wu, Tyler J. Curiel, Sharareh Emadi, Andleeb Zameer, Yuri L. Lyubchenko, Gaddam Narsa Goud, Philip Schulz, Ruitian Liu and Michael R. Sierks and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Biochemistry.

In The Last Decade

Bin Yuan

18 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bin Yuan China 11 167 137 102 97 43 19 410
Miriam Diament Argentina 11 184 1.1× 99 0.7× 66 0.6× 126 1.3× 66 1.5× 23 366
María E. Sabbatini United States 14 296 1.8× 202 1.5× 117 1.1× 44 0.5× 41 1.0× 26 612
Silvia Siteni United States 9 270 1.6× 119 0.9× 148 1.5× 73 0.8× 61 1.4× 13 508
Christopher C. Pan United States 11 226 1.4× 77 0.6× 75 0.7× 82 0.8× 75 1.7× 16 445
Zhenlian Wang China 12 378 2.3× 111 0.8× 62 0.6× 128 1.3× 108 2.5× 19 615
Aintzane Apraiz Spain 13 316 1.9× 96 0.7× 80 0.8× 74 0.8× 87 2.0× 20 489
Kevin Brady United Kingdom 13 242 1.4× 71 0.5× 160 1.6× 75 0.8× 57 1.3× 29 591
Roberto Arriga Italy 15 217 1.3× 318 2.3× 257 2.5× 72 0.7× 37 0.9× 24 656
Evert Nijhuis Netherlands 9 180 1.1× 51 0.4× 130 1.3× 73 0.8× 42 1.0× 9 429

Countries citing papers authored by Bin Yuan

Since Specialization
Citations

This map shows the geographic impact of Bin Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Yuan more than expected).

Fields of papers citing papers by Bin Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Yuan. The network helps show where Bin Yuan may publish in the future.

Co-authorship network of co-authors of Bin Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Yuan. A scholar is included among the top collaborators of Bin Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Yuan. Bin Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Ling, Bin Yuan, Fei Luo, et al.. (2024). Phosphorylation determines the glucose metabolism reprogramming and tumor-promoting activity of sine oculis homeobox 1. Signal Transduction and Targeted Therapy. 9(1). 337–337. 3 indexed citations
2.
Yuan, Bin, et al.. (2023). Ischemic stroke protected by ISO-1 inhibition of apoptosis via mitochondrial pathway. Scientific Reports. 13(1). 2788–2788. 12 indexed citations
3.
Wu, Bogang, Xiaowen Zhang, Huai-Chin Chiang, et al.. (2022). RNA polymerase II pausing factor NELF in CD8+ T cells promotes antitumor immunity. Nature Communications. 13(1). 2155–2155. 9 indexed citations
4.
Yuan, Bin, Curtis A. Clark, Bogang Wu, et al.. (2021). Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch. Journal for ImmunoTherapy of Cancer. 9(1). e001932–e001932. 34 indexed citations
5.
Wang, Zhanhuai, Qi Yang, Yinuo Tan, et al.. (2021). Cancer-Associated Fibroblasts Suppress Cancer Development: The Other Side of the Coin. Frontiers in Cell and Developmental Biology. 9. 613534–613534. 50 indexed citations
6.
Yang, Jing, et al.. (2021). BRCA1 Antibodies Matter. International Journal of Biological Sciences. 17(12). 3239–3254. 4 indexed citations
7.
Wu, Bogang, Huai-Chin Chiang, Xiujie Sun, et al.. (2021). Abstract PR004: Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammation. Cancer Immunology Research. 9(2_Supplement). PR004–PR004.
8.
Wu, Bogang, Huai-Chin Chiang, Xiujie Sun, et al.. (2020). Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammation. Journal for ImmunoTherapy of Cancer. 8(2). e000964–e000964. 16 indexed citations
9.
Wang, Chaowei, Pengju Ma, Yangyang Wang, et al.. (2019). Serum level of macrophage migration inhibitory factor predicts severity and prognosis in patients with ischemic stroke. Cytokine. 115. 8–12. 16 indexed citations
10.
Wu, Bogang, Xiujie Sun, Harshita B. Gupta, et al.. (2018). Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer. OncoImmunology. 7(11). e1500107–e1500107. 76 indexed citations
11.
Li, Weijun, Rui‐Xing Yin, Jianhua Huang, et al.. (2018). Association between the PPP1R3B polymorphisms and serum lipid traits, the risk of coronary artery disease and ischemic stroke in a southern Chinese Han population. Nutrition & Metabolism. 15(1). 27–27. 24 indexed citations
12.
Sun, Xiujie, Kshama Gupta, Bogang Wu, et al.. (2018). Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice. Journal of Biological Chemistry. 293(8). 2841–2849. 21 indexed citations
13.
Zhang, Lijun, Pengju Ma, Lei Meng, et al.. (2018). Effect of chemokine CC ligand 2 (CCL2) on α‑synuclein‑induced microglia proliferation and neuronal apoptosis. Molecular Medicine Reports. 18(5). 4213–4218. 9 indexed citations
14.
Gao, Hui, Rui‐Xing Yin, Qinghui Zhang, et al.. (2017). Association of RBM5 rs2013208 SNP with serum lipid levels in two Chinese ethnic groups.. PubMed. 10(8). 8520–8534. 2 indexed citations
15.
Sun, Jiaqi, Rui‐Xing Yin, Xia Chen, et al.. (2015). Association of the ARL15 rs6450176 SNP and serum lipid levels in the Jing and Han populations.. PubMed. 8(10). 12977–94. 15 indexed citations
16.
Yin, Rui‐Xing, et al.. (2015). Suppressor of cytokine signaling 3 A+930-->G (rs4969168) polymorphism is associated with apolipoprotein A1 and low-density lipoprotein cholesterol.. PubMed. 8(6). 7305–17. 10 indexed citations
17.
Yin, Rui‐Xing, et al.. (2015). Association of the SPT2 chromatin protein domain containing 1 gene rs17579600 polymorphism and serum lipid traits.. International Journal of Clinical and Experimental Pathology. 8(10). 12995–3010. 3 indexed citations
18.
Yin, Rui‐Xing, et al.. (2015). Sex-specific association of the SPTY2D1 rs7934205 polymorphism and serum lipid levels.. International Journal of Clinical and Experimental Pathology. 8(1). 665–81. 9 indexed citations
19.
Liu, Ruitian, Bin Yuan, Sharareh Emadi, et al.. (2004). Single Chain Variable Fragments against β-Amyloid (Aβ) Can Inhibit Aβ Aggregation and Prevent Aβ-Induced Neurotoxicity. Biochemistry. 43(22). 6959–6967. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026